The Mumbai-based Siro Clinpharm has signed a strategic partnership agreement with the Washington-based Spacelabs Medical Data, a leading provider of regulatory compliant centralized ECG, Holter, Ambulatory Blood Pressure monitoring and other cardiac research services for phase I-IV clinical research trials. With the tie up, Spacelabs Medical Data will furnish core ECG and cardiac safety and efficacy services for clinical studies that SIRO conducts in India for its clients.

Revealing this tie-up with the US CRO, Dr. Gautam Daftary, executive director, SIRO Clinpharm, told Pharmabiz that the Spacelabs Medical Data with state-of-the art technology and sponsor-specific solutions, will work closely with SIRO in providing critical data in a timely and cost-effective manner. "The addition of core ECG services through Medical Data will allow us to offer our clients a unified end-to-end solution for their clinical research needs in India," said Dr. Gautam Daftary.

"Spacelabs Medical Data has nearly two decades of successful experience in providing centralized services in more than 80 countries worldwide. The alliance with SIRO will benefit us by extending our operational reach in the emerging clinical research market of India," said Spacelabs Medical Data's general manager Marc Hagan.

Spacelabs Medical Data, a division of Spacelabs Medical Inc., has performed extensive cardiovascular procedures for virtually all of the major pharmaceutical companies, as well as biotech firms, universities, contract research organizations and device manufacturers. The company provides centralized monitoring, collection and analysis of data from ECG, Holter (ambulatory ECG), ABP (ambulatory blood pressure) and event monitors. Its cardiovascular specialists analyze and interpret cardiac physiological measurements that substantiate findings in the assessment of safety and/or efficacy of drug therapies. Spacelabs Medical is at present an OSI Systems company in the US.

While SIRO Clinpharm, one of the first CROs and the largest in India founded in 1995, offers comprehensive, independent management of phase II - IV clinical trials. Working with more than 100 hospitals and medical research centres throughout India, SIRO provides full clinical development services to pharmaceutical, biotech and medical device companies from North America, Europe, Japan and India.